Блог
Последни новини, научни статии и полезна информация за молекулярната онкологична диагностика и персонализираната терапия.
Dr. Teresa Montagut Appointed as Clinical Development and Medical Affairs Head at Mesoblast
NEW YORK, March 11, 2026 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today announced the appointment of Teresa Montagut MD, PhD in the newly established position of He…
Candel Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Corporate Highlights
NEEDHAM, Mass., March 12, 2026 (GLOBE NEWSWIRE) -- Candel Therapeutics, Inc. (Candel or the Company) (Nasdaq: CADL), a clinical-stage biopharmaceutical company focused on developing multimodal immunotherapies to help patients fight cancer, today announced fin…
Merck Price Prediction: Sac-TMT Drug Potential Pushes MRK to $150
Merck & Co., Inc. (NYSE:MRK) has been on a strong recovery run, gaining 23% over the past year and 8% year-to-date, though the stock has pulled back some...
Tecvayli (Johnson & Johnson) Market Research Report 2026: Epidemiology, Pipeline Analysis, Trends, Strategies, and Forecasts, 2020-2025, 2025-2030F, 2035F
Key market opportunities include expanding next-gen immuno-oncology and personalized therapies, increased multiple myeloma prevalence fueling demand for Tecvayli, rising investment in cancer research, and growing adoption of bcma-targeted and bispecific antib…
TICE BCG (Merck) Market Research Report 2026: Epidemiology, Pipeline Analysis, Trends, Strategies, and Forecasts, 2020-2025, 2025-2030F, 2035F
Key market opportunities include expanding bladder cancer screening programs, optimizing dosing regimens, increasing uro-oncology research investments, and growing demand for non-surgical treatments. Personalized medicine and higher healthcare spending also f…
Страница 1 от 13 • Общо 75 статии